VERU INC Earnings Estimate
VERU INC Earnings per Share Projection vs Actual
About VERU INC Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of VERU INC earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current VERU INC estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as VERU INC fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3 people.
Currently Active Assets on Macroaxis
Other Information on Investing in VERU Stock
VERU INC financial ratios help investors to determine whether VERU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VERU with respect to the benefits of owning VERU INC security.